Abstract
The incidence of inflammatory bowel disease (IBD) is increasing, and as our population ages, there is a growing number of IBD patients who are transitioning into advanced age; 15% to 20% of IBD patients are classified as late-onset (between 60-65 years of age). This has led clinicians to treat a large number of older patients with IBD. The principles of management of IBD in older patients are the same as those who are younger. There are, however, phenotypic differences that are unique to late-onset IBD and age-related concerns that clinicians must consider when initiating therapy for their older patients with IBD. Given the increasing number of older IBD patients, the aim of this article is to present an updated, evidence-based review of the therapeutic options and issues that arise in this unique patient population.
Original language | English |
---|---|
Pages (from-to) | 1155-1166 |
Number of pages | 12 |
Journal | Inflammatory Bowel Diseases |
Volume | 24 |
Issue number | 6 |
DOIs | |
Publication status | Published - May 18 2018 |
Bibliographical note
Publisher Copyright:© 2018 Crohn's & Colitis Foundation. Published by Oxford University Press. All rights reserved.
ASJC Scopus Subject Areas
- Immunology and Allergy
- Gastroenterology